m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia

m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia

RNA N6-methyladenosine (m6A) is the most common and intensively studied RNA modification that critically regulates RNA metabolism, cell signaling, cell survival, and differentiation. However, the overall role of multiple m6A regulators in the tumor microenvironment (TME) has not yet been fully eluci...

Full description

Bibliographic Details
Main Authors:	Zi-Jun Xu, Xiang-Mei Wen, Yuan-Cui Zhang, Ye Jin, Ji-Chun Ma, Yu Gu, Xin-Yi Chen, Pei-Hui Xia, Wei Qian, Jiang Lin, Jun Qian
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Genetics
Subjects:	m6A acute myeloid leukemia tumor microenvironment immune infiltration metabolic pathways
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.948079/full

Similar Items

Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia
by: Xiang-mei Wen, et al.
Published: (2021-10-01)

Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia
by: Zi‐jun Xu, et al.
Published: (2023-01-01)

Integrated analysis reveals distinct molecular, clinical, and immunological features of B7‐H3 in acute myeloid leukemia
by: Ling‐yi Zhang, et al.
Published: (2021-11-01)

The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia
by: Zi-Jun Xu, et al.
Published: (2020-01-01)

ALOX5AP is a new prognostic indicator in acute myeloid leukemia
by: Xin-Yi Chen, et al.
Published: (2023-11-01)

Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes
by: Jing-dong Zhou, et al.
Published: (2022-06-01)

Predicting the influence of Circ_0059706 expression on prognosis in patients with acute myeloid leukemia using classical statistics and machine learning
by: Jichun Ma, et al.
Published: (2022-10-01)

Clinical and prognostic relevance of CXCL12 expression in acute myeloid leukemia
by: Shi-sen Wang, et al.
Published: (2021-07-01)

The Down-Regulation of Circ_0059707 in Acute Myeloid Leukemia Promotes Cell Growth and Inhibits Apoptosis by Regulating miR-1287-5p
by: Jichun Ma, et al.
Published: (2022-09-01)

Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia
by: Zi-jun Xu, et al.
Published: (2022-09-01)

Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia
by: Zi-jun Xu, et al.
Published: (2019-03-01)

Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine
by: Li-juan Tang, et al.
Published: (2019-07-01)

Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia
by: Jing-dong Zhou, et al.
Published: (2018-05-01)

SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia
by: De-long Wu, et al.
Published: (2022-11-01)

Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia
by: Fang‐yu Nan, et al.
Published: (2021-08-01)

DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis
by: Jing-dong Zhou, et al.
Published: (2022-07-01)

Collagen code in tumor microenvironment: Functions, molecular mechanisms, and therapeutic implications
by: Qian Zhang, et al.
Published: (2023-10-01)

Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis.
by: Xin-Yue Lian, et al.
Published: (2016-01-01)

Physical exercise reverses immuno-cold tumor microenvironment via inhibiting SQLE in non-small cell lung cancer
by: Zhi-Wen Luo, et al.
Published: (2023-08-01)

Hippocampal Mrp8/14 signaling plays a critical role in the manifestation of depressive-like behaviors in mice
by: Hong Gong, et al.
Published: (2018-09-01)

Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia
by: Fang-Min Zhong, et al.
Published: (2022-11-01)

Pluripotency-associated genes in human nasopharyngeal carcinoma CNE-2 cells are reactivated by a unique epigenetic sub-microenvironment
by: Zheng Fei-Meng, et al.
Published: (2010-02-01)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
by: Zi-Rong Jiang, et al.
Published: (2022-09-01)

Addition of Fibroblast-Stromal Cell Markers to Immune Synovium Pathotypes Better Predicts Radiographic Progression at 1 Year in Active Rheumatoid Arthritis
by: Xue-Pei Zhang, et al.
Published: (2021-11-01)

SREBP1 deficiency diminishes glutamate-mediated HT22 cell damage and hippocampal neuronal pyroptosis induced by status epilepticus
by: Xing Ye, et al.
Published: (2024-01-01)

Magnetic-activated cell sorting of nonapoptotic spermatozoa with a high DNA fragmentation index improves the live birth rate and decreases transfer cycles of IVF/ICSI
by: Jie Mei, et al.
Published: (2022-01-01)

DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia
by: Guo‐Kang Sun, et al.
Published: (2019-10-01)

Temporal and Spatial Regulation of miR-320 in the Uterus during Embryo Implantation in the Rat
by: Chun-Mei Liu, et al.
Published: (2010-02-01)

Myeloid-derived suppressor cells and nonresolving inflammatory cells in glioma microenvironment: molecular mechanisms and therapeutic strategies
by: Xiao-Yan Ji, et al.
Published: (2018-01-01)

A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia
by: Hai-Bin Zhang, et al.
Published: (2022-08-01)

Effects of the PLK4 inhibitor Centrinone on the biological behaviors of acute myeloid leukemia cell lines
by: Xing-Ru Mu, et al.
Published: (2022-08-01)

FoxO1 is a critical regulator of hepatocyte lipid deposition in chronic stress mice
by: Yun-zi Liu, et al.
Published: (2019-09-01)

Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2023 ASH annual meeting
by: Xubo Gong, et al.
Published: (2024-02-01)

miR-550a-5p Functions as a Tumor Promoter by Targeting LIMD1 in Lung Adenocarcinoma
by: Zi-Zhang Guo, et al.
Published: (2020-10-01)

Interleukin-35 Regulates Immune Microenvironment of Autoimmune Hepatitis Through Inducing the Expansion of Myeloid-Derived Suppressor Cells
by: Min Lian, et al.
Published: (2019-11-01)

MESHING STIFFNESS ANALYSIS OF CYCLOID STEEL BALL MESHING PAIR BASED ON THERMAL DEFORMATION
by: LIU XiangHui, et al.
Published: (2019-01-01)

New Saffold Cardiovirus in Children, China
by: Zi-qian Xu, et al.
Published: (2009-06-01)

FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer
by: Lu Lu, et al.
Published: (2023-12-01)

Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia
by: Jun-Feng Zhu, et al.
Published: (2022-10-01)

Comparative efficacy and tolerability of front-line treatments for newly diagnosed chronic-phase chronic myeloid leukemia: an update network meta-analysis
by: Lu Tang, et al.
Published: (2019-08-01)